Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.
作者信息
Zhang B Y, Chen M, Chen X C, Cao K, You Y, Qian Y J, Yu W K
机构信息
Department of Critical Care Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, No. 321 Zhongshan Road, Nanjing, Jiangsu Province 210008, China.
出版信息
Br J Surg. 2021 Jan 27;108(1):e9-e11. doi: 10.1093/bjs/znaa021.
Abstract
摘要
相似文献
1
Berberine reduces circulating inflammatory mediators in patients with severe COVID-19.
Br J Surg. 2021 Jan 27;108(1):e9-e11. doi: 10.1093/bjs/znaa021.
2
The role of berberine in Covid-19: potential adjunct therapy.
Inflammopharmacology. 2022 Dec;30(6):2003-2016. doi: 10.1007/s10787-022-01080-1. Epub 2022 Oct 2.
3
COVID-19: Some clinical questions after the first 4 months.
Eur J Clin Invest. 2020 Jul;50(7):e13326. doi: 10.1111/eci.13326. Epub 2020 Jul 5.
4
Comprehensive Landscape of Heparin Therapy for COVID-19.
Carbohydr Polym. 2021 Feb 15;254:117232. doi: 10.1016/j.carbpol.2020.117232. Epub 2020 Oct 22.
5
Rapid evolution of our understanding of the pathogenesis of COVID-19: Implications for therapy.
S Afr Med J. 2020 Oct 23;110(12):1180-1185. doi: 10.7196/SAMJ.2020.v110i12.15328.
6
Can Natural Polyphenols Help in Reducing Cytokine Storm in COVID-19 Patients?
Molecules. 2020 Dec 12;25(24):5888. doi: 10.3390/molecules25245888.
7
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
Front Immunol. 2021 May 19;12:670955. doi: 10.3389/fimmu.2021.670955. eCollection 2021.
8
Purposing Saikosaponins for the treatment of COVID-19.
Med Hypotheses. 2020 Jul;140:109782. doi: 10.1016/j.mehy.2020.109782. Epub 2020 Apr 23.
9
Flavonoids against the SARS-CoV-2 induced inflammatory storm.
Biomed Pharmacother. 2021 Jun;138:111430. doi: 10.1016/j.biopha.2021.111430. Epub 2021 Feb 25.
10
Immunomodulatory and Anti-Inflammatory Effects of Berberine in Lung Tissue and its Potential Application in Prophylaxis and Treatment of COVID-19.
Front Biosci (Landmark Ed). 2022 May 20;27(5):166. doi: 10.31083/j.fbl2705166.
引用本文的文献
1
Berberine Suppresses Influenza A Virus-Triggered Pyroptosis in Macrophages via Intervening in the mtROS-MAVS-NLRP3 Inflammasome Pathway.
Viruses. 2025 Apr 7;17(4):539. doi: 10.3390/v17040539.
2
Bile acids and coronavirus disease 2019.
Acta Pharm Sin B. 2024 May;14(5):1939-1950. doi: 10.1016/j.apsb.2024.02.011. Epub 2024 Feb 13.
3
New Insights into the Link between SARS-CoV-2 Infection and Renal Cancer.
Life (Basel). 2023 Dec 28;14(1):52. doi: 10.3390/life14010052.
4
Recent Applications of Protoberberines as Privileged Starting Materials for the Development of Novel Broad-Spectrum Antiviral Agents: A Concise Review (2017-2023).
ACS Pharmacol Transl Sci. 2023 Dec 28;7(1):48-71. doi: 10.1021/acsptsci.3c00292. eCollection 2024 Jan 12.
5
Neuroprotective Agents with Therapeutic Potential for COVID-19.
Biomolecules. 2023 Oct 27;13(11):1585. doi: 10.3390/biom13111585.
6
Evaluation of berberine pellet effect on clinical recovery time in COVID-19 outpatients: A pilot clinical trial.
Avicenna J Phytomed. 2023 May-Jun;13(3):265-279. doi: 10.22038/AJP.2022.21539.
7
Berberine improves central memory formation of CD8 T cells: Implications for design of natural product-based vaccines.
Acta Pharm Sin B. 2023 May;13(5):2259-2268. doi: 10.1016/j.apsb.2023.02.017. Epub 2023 Feb 28.
8
Identification of berberine as a potential therapeutic strategy for kidney clear cell carcinoma and COVID-19 based on analysis of large-scale datasets.
Front Immunol. 2023 Mar 23;14:1038651. doi: 10.3389/fimmu.2023.1038651. eCollection 2023.
9
A Review of and Its Component, Berberine, as an Antidiabetic and Antioxidant.
Molecules. 2023 Jan 29;28(3):1294. doi: 10.3390/molecules28031294.
10
The role of berberine in Covid-19: potential adjunct therapy.
Inflammopharmacology. 2022 Dec;30(6):2003-2016. doi: 10.1007/s10787-022-01080-1. Epub 2022 Oct 2.
本文引用的文献
1
Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea.
J Med Virol. 2021 Jan;93(1):61-63. doi: 10.1002/jmv.26119. Epub 2020 Jun 24.
2
Faecal calprotectin indicates intestinal inflammation in COVID-19.
Gut. 2020 Aug;69(8):1543-1544. doi: 10.1136/gutjnl-2020-321388. Epub 2020 Apr 20.
3
Berberine suppresses influenza virus-triggered NLRP3 inflammasome activation in macrophages by inducing mitophagy and decreasing mitochondrial ROS.
J Leukoc Biol. 2020 Jul;108(1):253-266. doi: 10.1002/JLB.3MA0320-358RR. Epub 2020 Apr 9.
4
Clinical characteristics of 25 death cases with COVID-19: A retrospective review of medical records in a single medical center, Wuhan, China.
Int J Infect Dis. 2020 May;94:128-132. doi: 10.1016/j.ijid.2020.03.053. Epub 2020 Apr 3.
5
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
6
Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice.
Biomed Pharmacother. 2019 Oct;118:109206. doi: 10.1016/j.biopha.2019.109206. Epub 2019 Jul 12.
7
In vivo and in vitro antiviral effects of berberine on influenza virus.
Chin J Integr Med. 2011 Jun;17(6):444-52. doi: 10.1007/s11655-011-0640-3. Epub 2011 Jun 10.
Zotero 插件